Subscribe to Newsletter

Clinical Trials

Discovery & Development Clinical Trials

Clinical Trials: Decentralization and Digital Chaos

| Katrina Rice | 5 min read

Modern data strategies are needed as the landscape for clinical trials changes.

Discovery & Development Clinical Trials

Digitally Decentralized by Design

| Rob Coker | 3 min read

Through a partnership with software developer Medable, Syneos Health aims to decentralize and personalize clinical trials.

Discovery & Development Clinical Trials

The World’s Most Studied Disease

| Rob Coker | 5 min read

Breast cancer was the most researched disease in 2022. Phesi CEO Gen Li discusses what helps and what hinders the breast cancer research process.

Discovery & Development Clinical Trials

Putting Real-World Data to Work

| Karen Ooms | 4 min read

How do we further integrate real-world data into clinical research and approval processes?

Discovery & Development Drug Delivery

Connected Patient-Centricity

| Oliver Eden | 5 min read

How digital health technology can help clinical trials be more inclusive and accessible.

Discovery & Development Clinical Trials

Save One Person and You Heal the World

| Angus Stewart | 8 min read

An inside view on the French pharma company and Swiss NPO working on a treatment for a debilitating rare disease

Business & Regulation Business Practice

It’s a Material World…

| Angus Stewart | 2 min read

Growth, expansion, and acquisitions in Germany are on the menu for this global testing and safety company – here’s why

Discovery & Development Clinical Trials

Cancer Clinical Trials: The Where’s Waldo? Puzzle No One Wants

| Selin Kurnaz, Arturo Loaiza-Bonilla | 7 min read

The problem finding eligible patients for oncology clinical trials – and the tech-driven solution

Business & Regulation Profession

Pharma and Fordism

| Angus Stewart | 10 min read

Sitting Down With… Gen Li, CEO, Phesi

Discovery & Development Clinical Trials

Why Sex Matters in Drug Development

| Emma Banks | 3 min read

Why conversations on gender in drug development must go further.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register